Sugai S, Takiguchi T, Hirose Y, Konaka Y, Shimizu S, Konda S
Jpn J Clin Oncol. 1983 Sep;13(3):533-42.
We studied cell surface membrane immunoglobulins (SmIg), intracytoplasmic Ig (CIg) and monoclonal Ig (M protein) in patients with the B-cell series malignancies; malignant lymphoma, chronic lymphocytic leukemia (CLL), Waldenström's macroglobulinemia (WM), multiple myeloma (MM), and monoclonal gammopathy (MG) associated with Sjögren's syndrome (SS). The patients were examined for idyotype (Id) determinants on the cell surface and in the cytoplasm of malignant cells as well as serum M proteins. Twenty-two patients had malignant lymphoma with monoclonal SmIg. The malignant cells of 11 patients contained CIg; four of these 11 patients had a small amount of serum M protein. SmIg of the IgM class was most frequent (12/22) and the lambda type light chain was predominant (kappa/lambda ratio = 4/8). By means of rabbit anti-Id antisera prepared against M proteins, Id determinants were demonstrated on the cell surface and in the cytoplasm of malignant cells as well as in the serum M proteins, indicating that the malignant cells proliferated monoclonally producing monoclonal IgM on the cell surface and in the cytoplasm and secreting it to the serum. Six CLL patients were included in our series; one manifested monoclonal IgM in the serum. The Id determinants of M protein was detected on the cell surface and in the cytoplasm of pathologic cells in the peripheral blood. Eight of ten WM patients were examined for SmIg; all had monoclonal SmIg on the surface of cells from peripheral blood or bone marrow. Id determinants were detected on the cell surface and in the cytoplasm of malignant cells in four WM patients. There were 42 patients with MM; 10 of them were examined for SmIg and three of these had monoclonal SmIg on plasma cells derived from the bone marrow. By immunofluorescent and mixed rosette methods, Id-bearing B (0-20%) and T cells (0-2%) were identified in the peripheral blood of MM patients who had no plasma cells in the peripheral blood. Our findings suggest that a monoclonal change may occur at the B-cell level and that Id-bearing T cells may exist as regulatory T cells. Ten SS patients had M proteins. Non-IgM class M proteins (2 IgG and 4 IgA) were more frequent than the IgM class (3 IgM). Four M proteins with rheumatoid factor (RF) activity were found among these 10 M proteins.(ABSTRACT TRUNCATED AT 400 WORDS)
我们研究了B细胞系恶性肿瘤患者的细胞表面膜免疫球蛋白(SmIg)、胞质内免疫球蛋白(CIg)和单克隆免疫球蛋白(M蛋白),这些患者包括恶性淋巴瘤、慢性淋巴细胞白血病(CLL)、华氏巨球蛋白血症(WM)、多发性骨髓瘤(MM)以及与干燥综合征(SS)相关的单克隆丙种球蛋白病(MG)。对患者恶性细胞的细胞表面和胞质以及血清M蛋白进行了独特型(Id)决定簇检测。22例患者患有伴有单克隆SmIg的恶性淋巴瘤。11例患者的恶性细胞含有CIg;这11例患者中有4例血清中有少量M蛋白。IgM类SmIg最为常见(12/22),λ型轻链占主导(κ/λ比值 = 4/8)。通过针对M蛋白制备的兔抗Id抗血清,在恶性细胞的细胞表面和胞质以及血清M蛋白中均检测到了Id决定簇,这表明恶性细胞呈单克隆增殖,在细胞表面和胞质中产生单克隆IgM并分泌到血清中。我们的研究系列纳入了6例CLL患者;1例血清中出现单克隆IgM。在其外周血病理细胞的细胞表面和胞质中检测到了M蛋白的Id决定簇。10例WM患者中的8例检测了SmIg;所有患者外周血或骨髓细胞表面均有单克隆SmIg。4例WM患者的恶性细胞的细胞表面和胞质中检测到了Id决定簇。有42例MM患者;其中10例检测了SmIg,3例骨髓来源的浆细胞上有单克隆SmIg。通过免疫荧光和混合花环法,在无外周血浆细胞的MM患者外周血中鉴定出了携带Id的B细胞(0 - 20%)和T细胞(0 - 2%)。我们的研究结果表明,B细胞水平可能发生单克隆改变,且携带Id的T细胞可能作为调节性T细胞存在。10例SS患者有M蛋白。非IgM类M蛋白(2例IgG和4例IgA)比IgM类(3例IgM)更常见。在这10种M蛋白中发现了4种具有类风湿因子(RF)活性的M蛋白。(摘要截选至400字)